Syndax Pharmaceuticals Stock Price History
| SNDX Stock | USD 16.73 0.64 3.98% |
Below is the normalized historical share price chart for Syndax Pharmaceuticals extending back to March 03, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Syndax Pharmaceuticals stands at 16.73, as last reported on the 26th of November, with the highest price reaching 17.50 and the lowest price hitting 16.36 during the day.
If you're considering investing in Syndax Stock, it is important to understand the factors that can impact its price. Syndax Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0568, which indicates the firm had a -0.0568% return per unit of risk over the last 3 months. Syndax Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Syndax Pharmaceuticals' Risk Adjusted Performance of (0.04), variance of 16.53, and Coefficient Of Variation of (1,553) to confirm the risk estimate we provide.
At this time, Syndax Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 643.5 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 38.8 M in 2024. . At this time, Syndax Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 2.88 in 2024, whereas Price To Sales Ratio is likely to drop 6.97 in 2024. Syndax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of March 2016 | 200 Day MA 20.7581 | 50 Day MA 18.5994 | Beta 0.917 |
Syndax |
Sharpe Ratio = -0.0568
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SNDX |
Estimated Market Risk
| 4.18 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Syndax Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Syndax Pharmaceuticals by adding Syndax Pharmaceuticals to a well-diversified portfolio.
Price Book 3.748 | Enterprise Value Ebitda (105.26) | Price Sales 85.8378 | Shares Float 85 M | Wall Street Target Price 37.2857 |
Syndax Pharmaceuticals Stock Price History Chart
There are several ways to analyze Syndax Stock price data. The simplest method is using a basic Syndax candlestick price chart, which shows Syndax Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 8, 2024 | 21.81 |
| Lowest Price | November 21, 2024 | 15.6 |
Syndax Pharmaceuticals November 26, 2024 Stock Price Synopsis
Various analyses of Syndax Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Syndax Stock. It can be used to describe the percentage change in the price of Syndax Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Syndax Stock.| Syndax Pharmaceuticals Price Daily Balance Of Power | 0.56 | |
| Syndax Pharmaceuticals Price Action Indicator | 0.12 | |
| Syndax Pharmaceuticals Price Rate Of Daily Change | 1.04 | |
| Syndax Pharmaceuticals Accumulation Distribution | 122,686 |
Syndax Pharmaceuticals November 26, 2024 Stock Price Analysis
Syndax Stock Price History Data
The price series of Syndax Pharmaceuticals for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 6.21 with a coefficient of variation of 7.77. The price distribution for the period has arithmetic mean of 18.88. The median price for the last 90 days is 18.94.| Open | High | Low | Close | Volume | ||
| 11/25/2024 | 16.36 | 17.50 | 16.36 | 16.73 | 1,883,334 | |
| 11/22/2024 | 15.67 | 16.26 | 15.41 | 16.09 | 1,465,047 | |
| 11/21/2024 | 16.06 | 16.27 | 15.00 | 15.60 | 4,631,278 | |
| 11/20/2024 | 15.60 | 16.19 | 15.34 | 15.95 | 1,273,083 | |
| 11/19/2024 | 16.13 | 16.20 | 15.63 | 15.77 | 1,488,735 | |
| 11/18/2024 | 16.46 | 16.90 | 15.73 | 16.11 | 5,694,940 | |
| 11/15/2024 | 16.91 | 16.91 | 15.50 | 15.83 | 5,023,028 | |
| 11/14/2024 | 16.73 | 17.87 | 16.58 | 16.79 | 2,186,349 | |
| 11/13/2024 | 16.12 | 17.12 | 16.03 | 16.63 | 3,071,809 | |
| 11/12/2024 | 16.27 | 17.35 | 16.12 | 16.21 | 8,372,925 | |
| 11/11/2024 | 22.33 | 22.50 | 21.55 | 21.78 | 923,199 | |
| 11/08/2024 | 21.54 | 22.02 | 21.31 | 21.81 | 907,058 | |
| 11/07/2024 | 21.40 | 21.93 | 21.19 | 21.52 | 1,116,210 | |
| 11/06/2024 | 21.60 | 22.26 | 20.34 | 21.35 | 3,839,712 | |
| 11/05/2024 | 19.10 | 19.80 | 18.75 | 19.69 | 1,733,984 | |
| 11/04/2024 | 19.00 | 19.38 | 18.56 | 18.94 | 1,341,964 | |
| 11/01/2024 | 19.19 | 19.31 | 18.70 | 18.98 | 687,889 | |
| 10/31/2024 | 18.76 | 19.25 | 18.67 | 18.86 | 680,960 | |
| 10/30/2024 | 18.85 | 19.11 | 18.78 | 18.92 | 457,029 | |
| 10/29/2024 | 19.06 | 19.35 | 18.81 | 19.08 | 473,086 | |
| 10/28/2024 | 18.94 | 19.56 | 18.76 | 19.21 | 661,424 | |
| 10/25/2024 | 19.22 | 19.60 | 18.74 | 18.75 | 551,276 | |
| 10/24/2024 | 19.28 | 19.32 | 18.77 | 18.99 | 813,457 | |
| 10/23/2024 | 19.13 | 19.30 | 18.51 | 18.54 | 670,403 | |
| 10/22/2024 | 19.13 | 19.56 | 18.96 | 19.16 | 998,981 | |
| 10/21/2024 | 19.60 | 19.64 | 19.11 | 19.53 | 483,616 | |
| 10/18/2024 | 19.92 | 20.17 | 19.44 | 19.71 | 705,958 | |
| 10/17/2024 | 19.78 | 19.99 | 19.14 | 19.89 | 718,596 | |
| 10/16/2024 | 19.91 | 20.24 | 19.78 | 19.89 | 692,979 | |
| 10/15/2024 | 19.86 | 20.10 | 19.60 | 19.75 | 784,820 | |
| 10/14/2024 | 19.06 | 19.96 | 19.02 | 19.82 | 684,980 | |
| 10/11/2024 | 18.16 | 19.22 | 18.16 | 19.13 | 559,062 | |
| 10/10/2024 | 18.18 | 18.33 | 17.83 | 18.20 | 638,095 | |
| 10/09/2024 | 18.37 | 18.56 | 18.13 | 18.32 | 484,300 | |
| 10/08/2024 | 18.35 | 18.92 | 18.30 | 18.38 | 666,922 | |
| 10/07/2024 | 18.77 | 18.84 | 18.04 | 18.26 | 602,701 | |
| 10/04/2024 | 18.83 | 19.10 | 18.72 | 18.82 | 559,765 | |
| 10/03/2024 | 19.38 | 19.38 | 18.67 | 18.69 | 768,073 | |
| 10/02/2024 | 19.78 | 19.91 | 19.30 | 19.44 | 886,724 | |
| 10/01/2024 | 19.07 | 19.94 | 18.80 | 19.89 | 1,529,930 | |
| 09/30/2024 | 18.70 | 19.59 | 18.70 | 19.25 | 1,163,606 | |
| 09/27/2024 | 18.83 | 19.20 | 18.43 | 18.89 | 1,838,855 | |
| 09/26/2024 | 18.21 | 18.28 | 17.92 | 18.16 | 621,351 | |
| 09/25/2024 | 18.56 | 18.65 | 18.00 | 18.02 | 667,061 | |
| 09/24/2024 | 17.89 | 18.54 | 17.72 | 18.28 | 875,772 | |
| 09/23/2024 | 18.38 | 18.57 | 17.86 | 17.93 | 937,684 | |
| 09/20/2024 | 18.64 | 18.69 | 18.24 | 18.27 | 1,233,438 | |
| 09/19/2024 | 18.35 | 19.04 | 17.85 | 18.63 | 2,030,775 | |
| 09/18/2024 | 18.07 | 18.22 | 17.34 | 18.00 | 1,961,764 | |
| 09/17/2024 | 18.34 | 18.63 | 17.99 | 18.06 | 1,107,773 | |
| 09/16/2024 | 19.14 | 19.20 | 18.02 | 18.20 | 1,216,016 | |
| 09/13/2024 | 18.15 | 19.33 | 18.15 | 19.12 | 807,587 | |
| 09/12/2024 | 18.48 | 18.64 | 17.95 | 17.99 | 766,176 | |
| 09/11/2024 | 18.66 | 18.76 | 18.08 | 18.32 | 2,958,277 | |
| 09/10/2024 | 18.82 | 19.19 | 18.60 | 18.81 | 2,606,067 | |
| 09/09/2024 | 19.20 | 19.41 | 18.78 | 18.80 | 929,632 | |
| 09/06/2024 | 19.60 | 19.69 | 19.06 | 19.10 | 401,383 | |
| 09/05/2024 | 19.66 | 19.93 | 19.31 | 19.60 | 907,923 | |
| 09/04/2024 | 20.41 | 20.44 | 19.32 | 19.65 | 761,246 | |
| 09/03/2024 | 20.55 | 21.56 | 20.41 | 20.54 | 735,333 | |
| 08/30/2024 | 20.38 | 20.58 | 20.11 | 20.55 | 576,748 |
About Syndax Pharmaceuticals Stock history
Syndax Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Syndax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Syndax Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Syndax Pharmaceuticals stock prices may prove useful in developing a viable investing in Syndax Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 70.4 M | 38.8 M | |
| Net Loss | -134.4 M | -127.7 M |
Syndax Pharmaceuticals Quarterly Net Working Capital |
|
Syndax Pharmaceuticals Stock Technical Analysis
Syndax Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Syndax Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Syndax Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Syndax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Syndax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.91) | |||
| Treynor Ratio | (0.11) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Syndax Stock Analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.